StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

Equities research analysts at StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO) in a research note issued on Saturday. The firm set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Stock Performance

Shares of Global Cord Blood stock opened at $0.80 on Friday. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The company has a market cap of $97.24 million, a price-to-earnings ratio of 1.25 and a beta of 0.16. The business’s 50 day moving average price is $0.98 and its 200 day moving average price is $1.26.

Global Cord Blood Company Profile

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.